Literature DB >> 21821097

Amphetamine sensitization in reproductively experienced female rats.

John J Byrnes1, Robert S Bridges, Elizabeth M Byrnes.   

Abstract

Recent studies have supported the hypothesis that pregnancy and parturition are associated with altered sensitivity of brain dopamine systems. An increased behavioral sensitivity to a direct-acting D1/D2 receptor agonist (apomorphine) has also been observed several weeks after lactation, suggesting that these adaptations are long-lasting. To further characterize this phenomenon, the effects of reproductive experience on behavioral sensitization to an indirect-acting dopamine agonist (amphetamine) in female rats were studied. In two separate experiments, nulliparous and primiparous (12-16 weeks post-weaning) female rats were pretreated with amphetamine (1.0 or 5.0mg/kg) or vehicle (saline) once daily for 5 consecutive days. After 10 days of withdrawal, all animals were challenged with a low dose of amphetamine (25% of pretreatment dose). Locomotor activity was measured following each drug or vehicle administration. Locomotor sensitization to amphetamine challenge was observed in all animals pretreated with 1mg/kg, regardless of reproductive experience. In contrast, primiparous animals pretreated with 5mg/kg amphetamine displayed a significantly larger locomotor response to the challenge compared to nulliparous controls. The findings indicate enhanced behavioral sensitization to amphetamine in reproductively experienced rats, and confirm previous reports of lasting adaptations of dopamine systems following pregnancy and lactation.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821097      PMCID: PMC3167002          DOI: 10.1016/j.neulet.2011.07.035

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

1.  The nucleus accumbens shell is critical for normal expression of pup-retrieval in postpartum female rats.

Authors:  Ming Li; Alison S Fleming
Journal:  Behav Brain Res       Date:  2003-10-17       Impact factor: 3.332

2.  Postpartum psychosis with abnormal movements: dopamine supersensitivity unmasked by withdrawal of endogenous estrogens?

Authors:  S Vinogradov; J G Csernansky
Journal:  J Clin Psychiatry       Date:  1990-09       Impact factor: 4.384

3.  Reproductive experience modulates dopamine-related behavioral responses.

Authors:  E E Hucke; P E Cruz-Casallas; L H Sider; L F Felicio
Journal:  Pharmacol Biochem Behav       Date:  2001-03       Impact factor: 3.533

Review 4.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.

Authors:  P W Kalivas; J Stewart
Journal:  Brain Res Brain Res Rev       Date:  1991 Sep-Dec

5.  Positive treatment effect of estradiol in postpartum psychosis: a pilot study.

Authors:  A Ahokas; M Aito; R Rimón
Journal:  J Clin Psychiatry       Date:  2000-03       Impact factor: 4.384

6.  Estradiol levels in psychotic disorders.

Authors:  T J Huber; J Rollnik; J Wilhelms; A von zur Mühlen; H M Emrich; U Schneider
Journal:  Psychoneuroendocrinology       Date:  2001-01       Impact factor: 4.905

Review 7.  Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

Authors:  T E Robinson; J B Becker
Journal:  Brain Res       Date:  1986-06       Impact factor: 3.252

Review 8.  Postpartum mood disorders.

Authors:  L S Seyfried; S M Marcus
Journal:  Int Rev Psychiatry       Date:  2003-08

9.  Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth.

Authors:  A Wieck; R Kumar; A D Hirst; M N Marks; I C Campbell; S A Checkley
Journal:  BMJ       Date:  1991-09-14

10.  Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala.

Authors:  E M Nikulina; H E Covington; L Ganschow; R P Hammer; K A Miczek
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.